tumorsMalignant tumoursMalignant tumours2224-50572587-6813Rosoncoweb10.18027/2224-5057-2024-14-3s1-72-79tumors-1350Research ArticleСтатьиЧто надо знать о редко встречающихся возбудителях инфекций у онкологических больных?https://orcid.org/0000-0003-3077-0447ПетуховаИ. Н.

Ирина Николаевна Петухова 

115478 Москва, Каширское шоссе, 24

irinapet@list.ruhttps://orcid.org/0000-0003-4294-1995ГригорьевскаяЗ. В.

Григорьевская Злата Валерьевна

115478 Москва, Каширское шоссе, 24

https://orcid.org/0000-0003-1405-3536БагироваН. С.

Багирова Наталия Сергеевна

115478 Москва, Каширское шоссе, 24

125993 Москва, ул. Баррикадная, 2 / 1, стр. 1

https://orcid.org/0000-0003-1787-2676АгиноваВ. В.

Агинова Виктория Викторовна

115478 Москва, Каширское шоссе, 24

ФГБУ «НМИЦ онкологии им. Н. Н. Блохина» Минздрава РоссииRussian FederationФГБУ «НМИЦ онкологии им. Н. Н. Блохина» Минздрава России; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииRussian Federation202418112024143s17279Copyright © Петухова И.Н., Григорьевская З.В., Багирова Н.С., Агинова В.В., 20242024Петухова И.Н., Григорьевская З.В., Багирова Н.С., Агинова В.В.Петухова И.Н., Григорьевская З.В., Багирова Н.С., Агинова В.В.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.malignanttumors.org/jour/article/view/1350

Работа посвящена редко встречающимся бактериальным и грибковым возбудителям инфекций. Эти микроорганизмы создают трудности в диагностике и лечении в связи с возможными ошибками идентификации возбудителя, природной или приобретенной лекарственной резистентностью.

Возбудители редких инфекций могут колонизировать больных, образовывать биопленки, персистировать в окружающей среде, передаваться от больного к больному и приводить к развитию вспышек инфекции. Они нередко ухудшают прогноз лечения онкологического больного и приводят к летальному исходу.

Информация об особенностях редко встречающихся микроорганизмов и возможных подходах к их лечению позволит врачам-онкологам оказывать своевременную квалифицированную помощь подобным пациентам.

актиномицетынокардииMycobacterium tuberculosisнетуберкулезные микобактериикриптококкисахаромицетыGeotrichum spp.Trichosporon spp.фузариисцедоспориионкологические больныеReferencesMobedi I., Daee-Ghazvini F., Nakhjavani F.A., et al. Actinomyces naeslundii patients with hematological malignancies. Acta Medica Iranica 2006;44(5):345–348.Mobedi I., Daee-Ghazvini F., Nakhjavani F.A., et al. Actinomyces naeslundii patients with hematological malignancies. Acta Medica Iranica 2006;44(5):345–348.Pierre I., Zarrouk V., Noussar L., et al. . Invasive actinomycosis: a surrogate marker of a poor prognosis in immunocompromised patients. Int J Infect Dis 2014;29:74–79. https://doi.org/10.1016/j.ijid.2014.06.012Pierre I., Zarrouk V., Noussar L., et al. . Invasive actinomycosis: a surrogate marker of a poor prognosis in immunocompromised patients. Int J Infect Dis 2014;29:74–79. https://doi.org/10.1016/j.ijid.2014.06.012Dos Santos Menezes A.C., Daltro Borges Alves L., de Assis Ramos G., et al. The multiple presentation of oral actinomycosis in post-hematopoietic stem cell transplantation patients: case series. Hematol Transfus Cell Ther 2023:1–7. https://doi.org/10.1016/j.htct.2023.11.003Dos Santos Menezes A.C., Daltro Borges Alves L., de Assis Ramos G., et al. The multiple presentation of oral actinomycosis in post-hematopoietic stem cell transplantation patients: case series. Hematol Transfus Cell Ther 2023:1–7. https://doi.org/10.1016/j.htct.2023.11.003Бурова С.А. Актиномикоз. РМЖ 2001;3:146–148Бурова С.А. Актиномикоз. РМЖ 2001;3:146–148Чернеховская Н.Е., Бурова С.А., Поваляев А.В. Актиномикоз бронхов и легких. Пульмонология 2008;3:107–109. https://doi.org/10.18093/0869-0189-2008-0-3-107-109Чернеховская Н.Е., Бурова С.А., Поваляев А.В. Актиномикоз бронхов и легких. Пульмонология 2008;3:107–109. https://doi.org/10.18093/0869-0189-2008-0-3-107-109Torres H.A., Reddy B.T., Raad I.I., et al. Nocardiosis in cancer patients. Medicine (Baltimore) 2002;81(5):388–97. https://doi.org/10.1097/00005792-200209000-00004Torres H.A., Reddy B.T., Raad I.I., et al. Nocardiosis in cancer patients. Medicine (Baltimore) 2002;81(5):388–97. https://doi.org/10.1097/00005792-200209000-00004Lopes K., Montenegro C., Vilchez J., et al. IMAGES: Nocardia pneumonia – A surprising and rare pulmonary infection mimicking lung cancer. Pulmonology 2022;28(5):415–417. https://doi.org/10.1016/j.pulmoe.2022.03.013Lopes K., Montenegro C., Vilchez J., et al. IMAGES: Nocardia pneumonia – A surprising and rare pulmonary infection mimicking lung cancer. Pulmonology 2022;28(5):415–417. https://doi.org/10.1016/j.pulmoe.2022.03.013Kao H., Tsai C.A., Sun M.H., et al. Nocardia brain abscess in a patient of lung cancer. Int J Clin Med Imaging 2016;3(10):512. https://doi.org/10.4172/2376-0249.1000512Kao H., Tsai C.A., Sun M.H., et al. Nocardia brain abscess in a patient of lung cancer. Int J Clin Med Imaging 2016;3(10):512. https://doi.org/10.4172/2376-0249.1000512Petitgas P., Lesouhaitier M., Boukthir S., et al. Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report. BMC Infect Dis 2022;22:306. https://doi.org/10.1186/s12879-022-07288-4Petitgas P., Lesouhaitier M., Boukthir S., et al. Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report. BMC Infect Dis 2022;22:306. https://doi.org/10.1186/s12879-022-07288-4Lee E.K., Kim J., Park D.H., et al. Disseminated nocardiosis caused by Nocardia farcinica in a patient with colon cancer. A case report and literature review. Medicine 2021;100:29(e26682). https://doi.org/10.1097/MD.0000000000026682Lee E.K., Kim J., Park D.H., et al. Disseminated nocardiosis caused by Nocardia farcinica in a patient with colon cancer. A case report and literature review. Medicine 2021;100:29(e26682). https://doi.org/10.1097/MD.0000000000026682Yang M., Xu M., Wei W., et al. Clinical findings of 40 patients with nocardiosis: A retrospective analysis in a tertiary hospital. Exp Ther Med 2014;8(1):25–30. https://doi.org/10.3892/etm.2014.1715Yang M., Xu M., Wei W., et al. Clinical findings of 40 patients with nocardiosis: A retrospective analysis in a tertiary hospital. Exp Ther Med 2014;8(1):25–30. https://doi.org/10.3892/etm.2014.1715Al Akhrass F., Hachen R., Mohamed J.A., et al. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis 2011;17(9):1651. https://doi.org/103201/eid1709.101810Al Akhrass F., Hachen R., Mohamed J.A., et al. Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis 2011;17(9):1651. https://doi.org/103201/eid1709.101810Cattaneo C., Antoniazzi F., Caira M., et al. Nocardia spp. infections among hematological patients: results of a retrospective multicenter study. Int J Infect Dis 2013:17:e610-e614. https://doi.org/10.1016/j.ijid.2013.01.013Cattaneo C., Antoniazzi F., Caira M., et al. Nocardia spp. infections among hematological patients: results of a retrospective multicenter study. Int J Infect Dis 2013:17:e610-e614. https://doi.org/10.1016/j.ijid.2013.01.013Miyaoka C., Nakamoto K., Shirai T., et al. Pulmonary nocardiosis caused by Nocardia exalbida mimickimg lung cancer. Respirology Case Reports 2019;7(7):e00458. https://doi.org/10.1002/rcr2.458Miyaoka C., Nakamoto K., Shirai T., et al. Pulmonary nocardiosis caused by Nocardia exalbida mimickimg lung cancer. Respirology Case Reports 2019;7(7):e00458. https://doi.org/10.1002/rcr2.458Ansari S.R., Safdar A., Han X.Y., O`Brien S. Nocardia veterana bloodstream infection in a patient with cancer and a summary of reported cases. Int J Infect Dis 2006;10(6):483–6. https://doi.org/10.1016/j.ijid.2006.03.005Ansari S.R., Safdar A., Han X.Y., O`Brien S. Nocardia veterana bloodstream infection in a patient with cancer and a summary of reported cases. Int J Infect Dis 2006;10(6):483–6. https://doi.org/10.1016/j.ijid.2006.03.005Kmeid J., Kulkarni P.A., Batista M.V., et al. Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006–2014. BMC Infect Dis 2019;19(1):934. https://doi.org/10.1186/s12879-019-4586-yKmeid J., Kulkarni P.A., Batista M.V., et al. Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006–2014. BMC Infect Dis 2019;19(1):934. https://doi.org/10.1186/s12879-019-4586-yКомиссарова О., Михайловский А., Абдуллаев Р. Туберкулез легких и злокачественные новообразования. Врач 2020;2:3–6. https://doi.org/10.29296/25877305-2020-02-01Комиссарова О., Михайловский А., Абдуллаев Р. Туберкулез легких и злокачественные новообразования. Врач 2020;2:3–6. https://doi.org/10.29296/25877305-2020-02-01Kamboj M., Sepkowitz K.A. The risk of tuberculosis in patients with cancer. Clin Infect Dis 200. 6;42(11):1592–5. https://doi.org/10.1086/503917Kamboj M., Sepkowitz K.A. The risk of tuberculosis in patients with cancer. Clin Infect Dis 200. 6;42(11):1592–5. https://doi.org/10.1086/503917Dobler C.C., Cheung K., Nguen J., Martin A. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. Eur Respir J 2017;50(2):1700157. https://doi.org/10.1183/13993003.00157-2017Dobler C.C., Cheung K., Nguen J., Martin A. Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis. Eur Respir J 2017;50(2):1700157. https://doi.org/10.1183/13993003.00157-2017Siewchaisakul P., Nanthanangkul S., Santong C., et al. Survival of cancer patients with co-morbid tuberculosis in Thailand. Asian Pac J Cancer Prev 2021;22(8):2701–2708. https://doi.org/10.31557/APJCP.2021.22.8.2701Siewchaisakul P., Nanthanangkul S., Santong C., et al. Survival of cancer patients with co-morbid tuberculosis in Thailand. Asian Pac J Cancer Prev 2021;22(8):2701–2708. https://doi.org/10.31557/APJCP.2021.22.8.2701Kato Y., Watanabe Y., Yamane Y., et al. Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case report. Immunotherapy 2020;12(6):373–378. https://doi.org/10.2217/imt-2020-0061Kato Y., Watanabe Y., Yamane Y., et al. Reactivation of TB during administration of durvalumab after chemoradiotherapy for non-small-cell lung cancer: a case report. Immunotherapy 2020;12(6):373–378. https://doi.org/10.2217/imt-2020-0061Anastasopoulou A., Ziogas D.C., Samarkos M., et al. Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations. J Immunother Cancer 2019;7(1):239–251. https://doi,org/10.1186/s40425-019-0717-7Anastasopoulou A., Ziogas D.C., Samarkos M., et al. Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations. J Immunother Cancer 2019;7(1):239–251. https://doi,org/10.1186/s40425-019-0717-7Hirashima T., Tamura Y., Hashimoto S., et al. Efficacy and safety of concurrent anti-cancer and anti-tuberculosis chemotherapy in cancer patients with active Mycobacterium tuberculosis: a retrospective study. BMC Cancer 2018;18(1):975–984. https://doi.org/10.1186/s12885-018-4889-1Hirashima T., Tamura Y., Hashimoto S., et al. Efficacy and safety of concurrent anti-cancer and anti-tuberculosis chemotherapy in cancer patients with active Mycobacterium tuberculosis: a retrospective study. BMC Cancer 2018;18(1):975–984. https://doi.org/10.1186/s12885-018-4889-1Tadmori I., Benmiloud S., Habibi M., Hida M. Active tuberculosis in children receiving chemotherapy. Open Journal of Pediatrics 2022;12(1);75–78. https://doi.org/10.4236/ojped.2022.121009Tadmori I., Benmiloud S., Habibi M., Hida M. Active tuberculosis in children receiving chemotherapy. Open Journal of Pediatrics 2022;12(1);75–78. https://doi.org/10.4236/ojped.2022.121009Aldabbah M.A., Abughasham A., Alansari G.A., et al. The prevalence of Mycobacterium tuberculosis infection among cancer patients, receiving chemotherapy in a tertiary care center. Cureus 2022;14(11):e32068. https://doi.org/10.7759/cureus.32068Aldabbah M.A., Abughasham A., Alansari G.A., et al. The prevalence of Mycobacterium tuberculosis infection among cancer patients, receiving chemotherapy in a tertiary care center. Cureus 2022;14(11):e32068. https://doi.org/10.7759/cureus.32068Pennington K.M., Vu A., Ghallener D., et al. Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease. J Clin Tub Other Mycobact Dis 2021;24:100244. https://doi.org/10.1016/j.jctube.2021.100244Pennington K.M., Vu A., Ghallener D., et al. Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease. J Clin Tub Other Mycobact Dis 2021;24:100244. https://doi.org/10.1016/j.jctube.2021.100244Addisu A., Alok A., Binkam M., et al. Nontuberculous Mycobacterial isolates among cancer patients: A single-center 5-year experience. Infect Dis Clin Practice 2023;31(1):e1195. https://doi.org/10.1097/IPC.0000000000001195Addisu A., Alok A., Binkam M., et al. Nontuberculous Mycobacterial isolates among cancer patients: A single-center 5-year experience. Infect Dis Clin Practice 2023;31(1):e1195. https://doi.org/10.1097/IPC.0000000000001195Al-Anazi K.A., Al-Jasser A.M., Al-Anazi W.K. Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation. Front Oncol 2014;4:311. https://doi.org/10.3389/fonc.2014.00311Al-Anazi K.A., Al-Jasser A.M., Al-Anazi W.K. Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation. Front Oncol 2014;4:311. https://doi.org/10.3389/fonc.2014.00311Redelman-Sidi G., Sepkowitz K.A. Rapidly growing mycobacteria infection in patients with cancer. Clin Infect Dis 2010;51(4):422–434. https://doi.org/10.1086/655140Redelman-Sidi G., Sepkowitz K.A. Rapidly growing mycobacteria infection in patients with cancer. Clin Infect Dis 2010;51(4):422–434. https://doi.org/10.1086/655140Yoon H.J., Choi H.Y., Ki M. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea. BMC Infect Dis 2017;17(1):432. https://doi.org/10.1186/s12879-017-2532-4Yoon H.J., Choi H.Y., Ki M. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea. BMC Infect Dis 2017;17(1):432. https://doi.org/10.1186/s12879-017-2532-4Da Costa A.R.F., Falkinham J.O. 3rd, Lopez M.L., et al. Occurrence of nontuberculosis mycobacterial pulmonary infection in an endemic area of tuberculosis. PLoS Negl Trop Dis 2013;7(7):e2340. https://doi.org/10.1371/journal.pntd.0002340Da Costa A.R.F., Falkinham J.O. 3rd, Lopez M.L., et al. Occurrence of nontuberculosis mycobacterial pulmonary infection in an endemic area of tuberculosis. PLoS Negl Trop Dis 2013;7(7):e2340. https://doi.org/10.1371/journal.pntd.0002340Goswami P.N., Kishore A. Infections with yeast and yeast like fungi in cancer patients with special emphasis on non-neoformans cryptococcal infections: Retrospective study. Indian J Microbiol Res 2019;6(3):213–220. https://doi.org/10.18231/j.ijmr.2019.047Goswami P.N., Kishore A. Infections with yeast and yeast like fungi in cancer patients with special emphasis on non-neoformans cryptococcal infections: Retrospective study. Indian J Microbiol Res 2019;6(3):213–220. https://doi.org/10.18231/j.ijmr.2019.047Patel V., Desjardins M., Cowan J. Shift in epidemiology of Cryptococcal infections in Ottawa with high-mortality in Non-HIV immunocompromised patients. J Fungi 2019;5(4):104. https://doi.org/10.3390/jof5040104Patel V., Desjardins M., Cowan J. Shift in epidemiology of Cryptococcal infections in Ottawa with high-mortality in Non-HIV immunocompromised patients. J Fungi 2019;5(4):104. https://doi.org/10.3390/jof5040104Coussement J., Heath C.H., Roberts M.B., et al. Current epidemiology and clinical features of Cryptococcus infection in patients without human immunodeficiency virus: a multicenter study in 46 hospitals in Australia and New Zealand. Clin Infect Dis 2023;77(7):976–86. https://doi.org/10.1093/cid/ciad321Coussement J., Heath C.H., Roberts M.B., et al. Current epidemiology and clinical features of Cryptococcus infection in patients without human immunodeficiency virus: a multicenter study in 46 hospitals in Australia and New Zealand. Clin Infect Dis 2023;77(7):976–86. https://doi.org/10.1093/cid/ciad321Kontoyiannis D.P., Peitsch W.K., Reddy B.T., et al. Cryptococcosis in patients with cancer. Clin Infect Dis 2001;32(11):е145–50. https://doi.org/10.1086/320524Kontoyiannis D.P., Peitsch W.K., Reddy B.T., et al. Cryptococcosis in patients with cancer. Clin Infect Dis 2001;32(11):е145–50. https://doi.org/10.1086/320524Gangadharan S.S., Raveendranath S. Cryptococcosis in oncology patients: a case series in a tertiary care cancer centre. Iran J Microbiol 2023;15(6):821–825. https://doi.org/10.18502/ijm.v15i6.14163Gangadharan S.S., Raveendranath S. Cryptococcosis in oncology patients: a case series in a tertiary care cancer centre. Iran J Microbiol 2023;15(6):821–825. https://doi.org/10.18502/ijm.v15i6.14163Liu K., Ding H., Xu B., et al. Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis, J Thorac Dis 2016;8(10):2813–2821. https://doi.org/10.21037/jtd.2016.10.36Liu K., Ding H., Xu B., et al. Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis, J Thorac Dis 2016;8(10):2813–2821. https://doi.org/10.21037/jtd.2016.10.36Li H., Guo M., Wang C., et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiol Infect 2020;148:e169. https://doi.org/10.1017/S0950268820001624Li H., Guo M., Wang C., et al. Epidemiological study of Trichosporon asahii infections over the past 23 years. Epidemiol Infect 2020;148:e169. https://doi.org/10.1017/S0950268820001624Mehta V., Nayyar C., Gulati N., et al. A comprehensive review of Trichosporon spp.: An Invasive and Emerging Fungus. Cureus 2021;13(8):e17345. https://doi.org/10.77/cureus.17345Mehta V., Nayyar C., Gulati N., et al. A comprehensive review of Trichosporon spp.: An Invasive and Emerging Fungus. Cureus 2021;13(8):e17345. https://doi.org/10.77/cureus.17345Montoya A.M., Gonzalez G.M. Trichosporon spp.: an emerging fungal pathogen. Medicina Universitaria 2014:16(62):37–43Montoya A.M., Gonzalez G.M. Trichosporon spp.: an emerging fungal pathogen. Medicina Universitaria 2014:16(62):37–43Abbas A.A., Alamri A.W., Almofti A.H. Trichosporon asahii infection mortality in pediatric oncology patients: a report of six patients. J Microbiol Infect Dis 2020;10(3):167–172. https://doi.org/10.5799/jmid.790293Abbas A.A., Alamri A.W., Almofti A.H. Trichosporon asahii infection mortality in pediatric oncology patients: a report of six patients. J Microbiol Infect Dis 2020;10(3):167–172. https://doi.org/10.5799/jmid.790293Robles-Tenorio A., Rivas-Lopez R.A., Bonifaz A., Tarango-Martinez V.M. Disseminated mucocutaneous trichosporonosis in a patient with histiocytic sarcoma. An Bras Dermatol 2021;96(5):595–597. https://doi.org/10.1016/j.abd.2021.01.003Robles-Tenorio A., Rivas-Lopez R.A., Bonifaz A., Tarango-Martinez V.M. Disseminated mucocutaneous trichosporonosis in a patient with histiocytic sarcoma. An Bras Dermatol 2021;96(5):595–597. https://doi.org/10.1016/j.abd.2021.01.003Байбак О.И., Абугова Ю.Г., Пирумова Р.П. и соавт. Инвазивный микоз, вызванный Trichosporon mucoides. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2017;16(1):49–53. https://doi.org/10.24287/1726-1708-2017-16-1-49-53Байбак О.И., Абугова Ю.Г., Пирумова Р.П. и соавт. Инвазивный микоз, вызванный Trichosporon mucoides. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2017;16(1):49–53. https://doi.org/10.24287/1726-1708-2017-16-1-49-53El Omri H., Fathallah-Mili A., Ben Youssef Y., et al. Geotrichum capitatum septicemia in neutropenic patient, case report and review. Journal de Mycologie Medicale 2005;15(4):242–246. https://doi.org/10.1016/j.mycmed.2005.09.002El Omri H., Fathallah-Mili A., Ben Youssef Y., et al. Geotrichum capitatum septicemia in neutropenic patient, case report and review. Journal de Mycologie Medicale 2005;15(4):242–246. https://doi.org/10.1016/j.mycmed.2005.09.002Gao G.X., Tang H.L., Zhang X., et al. Invasive fungal infection caused by Geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review. Int J Clin Exp Med 2015;8(8):14228–14235.Gao G.X., Tang H.L., Zhang X., et al. Invasive fungal infection caused by Geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review. Int J Clin Exp Med 2015;8(8):14228–14235.Sulik-Tyszka B., Snarski E., Niedzwiedzka M., et al. Experience of Saccharomyces boulardii probiotic in oncohaematological patients. Probiotics & Antimicro Prot 2018;10(2):350–355. https://doi.org/10.1007/s12602-017-9332-4Sulik-Tyszka B., Snarski E., Niedzwiedzka M., et al. Experience of Saccharomyces boulardii probiotic in oncohaematological patients. Probiotics & Antimicro Prot 2018;10(2):350–355. https://doi.org/10.1007/s12602-017-9332-4Enache-Angoulvant A., Hennequin C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 2005;41(11):1559–68. https://doi.org/10.1086/497832Enache-Angoulvant A., Hennequin C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 2005;41(11):1559–68. https://doi.org/10.1086/497832Chakravarty S., Parashar A., Acharyya S. Saccharomyces cerevisiae sepsis following probiotic therapy in an infant. Indian Pediatr 2019;56(11):971–972Chakravarty S., Parashar A., Acharyya S. Saccharomyces cerevisiae sepsis following probiotic therapy in an infant. Indian Pediatr 2019;56(11):971–972Батманова Н.А., Багирова Н.С., Григорьевская З.В. и соавт. Успешная диагностика и лечение фузариоза у больной острым лейкозом. Гематология и трансфузиология 2022;67(1):139–149. https://doi.org/10.35754/0234-5730-2022-67-1-139-149Батманова Н.А., Багирова Н.С., Григорьевская З.В. и соавт. Успешная диагностика и лечение фузариоза у больной острым лейкозом. Гематология и трансфузиология 2022;67(1):139–149. https://doi.org/10.35754/0234-5730-2022-67-1-139-149Nucci M., Anassie E.J., Queiros-Telles F., et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003;98(2):315–319. https://doi.org/10.1002/cncr.11510Nucci M., Anassie E.J., Queiros-Telles F., et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003;98(2):315–319. https://doi.org/10.1002/cncr.11510Hoyos-Pulgarin J.A., Arias-Ramos D., Gonzalez-Diaz J.A., Ramirez N.M. Unusual finding in Gram staining of blood cultures in a patient with prolonged febrile neutropenia and acute myeloid leukemia. Enferm Infecc Microbiol Clin 2020;38(7):338–340. https://doi.org/10.1016/j.eimc.2019.12.015Hoyos-Pulgarin J.A., Arias-Ramos D., Gonzalez-Diaz J.A., Ramirez N.M. Unusual finding in Gram staining of blood cultures in a patient with prolonged febrile neutropenia and acute myeloid leukemia. Enferm Infecc Microbiol Clin 2020;38(7):338–340. https://doi.org/10.1016/j.eimc.2019.12.015Hayashida M.Z., Seque C.A., Simoes e Silva Enokihara M.M., Porro A.M. Disseminated fusariosis with cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate. An Bras Dermatol 2018;93(5):726–9. https://doi.org/10.1590/abd1806-4841.20187476Hayashida M.Z., Seque C.A., Simoes e Silva Enokihara M.M., Porro A.M. Disseminated fusariosis with cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate. An Bras Dermatol 2018;93(5):726–9. https://doi.org/10.1590/abd1806-4841.20187476Liu Y.S., Wang N.C., Ye R.H., Kao W.Y. Disseminated Fusarium infection in a patient with acute lymphoblastic leukemia: a case report and review of the literature. Oncol Lett 2014;7(2):334–336. https://doi.org/10.3892.ol.2013.1738Liu Y.S., Wang N.C., Ye R.H., Kao W.Y. Disseminated Fusarium infection in a patient with acute lymphoblastic leukemia: a case report and review of the literature. Oncol Lett 2014;7(2):334–336. https://doi.org/10.3892.ol.2013.1738Tortorano A.M., Prigetano A., Esposto M.C., et al. European Medical Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis 2014;33(9):1623–30. https://doi.org/10.1007/s10096-014-2111-1Tortorano A.M., Prigetano A., Esposto M.C., et al. European Medical Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis 2014;33(9):1623–30. https://doi.org/10.1007/s10096-014-2111-1Ferreira Chagas D., Martins Diniz L., Almeida Lucas E., Emerich Noguera P.S. Disseminated fusariosis in a patient with bone marrow aplasia. An Bras Dermatol 2020;95(5):609–614. https://doi.org/10.1016/j.abd.2019.12.008Ferreira Chagas D., Martins Diniz L., Almeida Lucas E., Emerich Noguera P.S. Disseminated fusariosis in a patient with bone marrow aplasia. An Bras Dermatol 2020;95(5):609–614. https://doi.org/10.1016/j.abd.2019.12.008Marinovic D.A., Bhaimia E., Forrest G.N., et al. Scedosporium infection disseminated “from toe to head ” in allogeneic stem cell transplant recipient: a case report. BMC Infect Dis 2023;23(1):353. https://doi.org/10.1186/s12879-023-08345-2Marinovic D.A., Bhaimia E., Forrest G.N., et al. Scedosporium infection disseminated “from toe to head ” in allogeneic stem cell transplant recipient: a case report. BMC Infect Dis 2023;23(1):353. https://doi.org/10.1186/s12879-023-08345-2Seidel D., Meissner A., Lackner M., et al. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and Fungiscope®. Crit Rev Microbiol 2019;45(1):1–21. https://doi.org/10.1080/1040841X.2018.1514Seidel D., Meissner A., Lackner M., et al. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and Fungiscope®. Crit Rev Microbiol 2019;45(1):1–21. https://doi.org/10.1080/1040841X.2018.1514Goldman C., Akiyama M.J., Torres J., et al. Scedosporium apiospermum and the role of combination antifungal therapy and GM-CSF: a case report and review of the literature. Med Mycol Case Rep 2016;11:40–43. https://doi.org/j.mmcr.2016.04.005Goldman C., Akiyama M.J., Torres J., et al. Scedosporium apiospermum and the role of combination antifungal therapy and GM-CSF: a case report and review of the literature. Med Mycol Case Rep 2016;11:40–43. https://doi.org/j.mmcr.2016.04.005Woolhouse M.E. Population biology of emerging and reemerging pathogens. Trends Microbiol 2002;10(10, Suppl.):S3-S7. https://doi.org/10.1016/s0966-842x(02)02428-9.Woolhouse M.E. Population biology of emerging and reemerging pathogens. Trends Microbiol 2002;10(10, Suppl.):S3-S7. https://doi.org/10.1016/s0966-842x(02)02428-9.

The authors declare that there are no conflicts of interest present.